Fed. Circ. Judge Slams Amgen Patent's 'Utter Lack Of Clarity'
The Federal Circuit grilled an Amgen Inc. attorney Monday over his inability to explain why a key term was deleted during the prosecution of a patent for the company's blockbuster anemia...To view the full article, register now.
Already a subscriber? Click here to view full article